newsfilter
← Latest News
GlobeNewswire·

20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy

AIDX
  • 20/20 BioLabs (NASDAQ: AIDX) will host an investor webinar on Wednesday, November 4, 2026, at 12:00 p.m. Eastern Time to discuss strategic initiatives.
  • CEO Jonathan Cohen will address the laboratory franchise model for OneTest™, including royalty-based structures and partner-funded customer acquisition.
  • The company outlined 2027 licensing plans to distribute its patented protein tumor marker approach for multi-cancer early detection testing to clinical laboratories globally.
  • A roll-up acquisition strategy targeting complementary businesses in health, wellness, longevity testing, and nutrition was presented as a means to expand the OneTest™ platform.
  • FDA strategy includes planning for OneTest™ for Cancer, referencing the September 23, 2026, advisory committee meeting on GRAIL's Galleri test, with a goal to achieve Medicare reimbursement by the end of 2028.
  • Potential Maryland legislation is expected to expand state-funded firefighter cancer screening, building on March 2026 awards totaling over $520,000 for 18 fire departments.
  • The webinar will feature a live question-and-answer session, a replay available on the investor relations website, and a promotional discount code for OneTest™ for all attendees.
  • Management confirmed the session will not discuss third quarter 2026 financial results or disclose material non-public information.
  • Forward-looking statements regarding franchise, licensing, acquisitions, and legislation are subject to risks, uncertainties, and the execution of definitive agreements.